Kim Wigglesworth Selected Research

Pharmaceutical Preparations

1/2019

AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim Wigglesworth Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 04/2007
3	Melanoma (Melanoma, Malignant) 01/2019 - 10/2009
2	Neoplasm Micrometastasis 10/2009 - 04/2007
1	Burns 03/2010
1	Wounds and Injuries (Trauma) 03/2010
1	Neoplasm Metastasis (Metastasis) 10/2009
1	Influenza in Birds (Avian Flu) 09/2007
1	Inflammation (Inflammations) 04/2007

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2019 - 04/2007
4	GlycolipidsIBA 01/2019 - 04/2007
4	Complement System Proteins (Complement)IBA 01/2019 - 04/2007
3	AntigensIBA 01/2019 - 10/2009
3	Peptides (Polypeptides)IBA 03/2010 - 04/2007
3	EpitopesIBA 01/2010 - 04/2007
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 10/2009
1	AntibodiesIBA 01/2019
1	Complement C2 (Complement Component 2)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	GalactosyltransferasesIBA 01/2019
1	Heterophile AntigensIBA 01/2019
1	Liposomes (Liposome)IBA 03/2010
1	CytokinesIBA 03/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2010
1	Immunoglobulins (Immunoglobulin)IBA 01/2010
1	IgG Receptors (Fc gamma RI)IBA 10/2009

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2019
2	Immunotherapy 01/2019 - 04/2007
1	Bandages (Bandage) 03/2010
1	Injections 01/2010